Nervgen Pharma Corp Stock Analysis

NervGen OTC Stock Analysis Notes

About 25.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.28. NervGen Pharma Corp had not issued any dividends in recent years. NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada. NERVGEN PHARMA operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for NervGen Pharma Corp is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about NervGen Pharma Corp contact the company at 778 731 1711 or learn more at https://www.nervgen.com.

NervGen Pharma Corp Investment Alerts

NervGen Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 87.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NervGen Pharma's market, we take the total number of its shares issued and multiply it by NervGen Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 29th of November, NervGen Pharma secures the Downside Deviation of 5.04, risk adjusted performance of 0.0266, and Mean Deviation of 3.24. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NervGen Pharma Corp, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for NervGen Pharma, which can be compared to its peers in the industry. Please verify NervGen Pharma Corp information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if NervGen Pharma Corp is priced some-what accurately, providing market reflects its recent price of 2.0 per share. Please also check out NervGen Pharma total risk alpha, which is currently at (0.61) to check the company can sustain itself at a future point.

NervGen Pharma Corp Price Movement Analysis

NervGen Pharma Predictive Daily Indicators

NervGen Pharma Forecast Models

NervGen Pharma's time-series forecasting models are one of many NervGen Pharma's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NervGen Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how NervGen Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NervGen shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as NervGen Pharma. By using and applying NervGen OTC Stock analysis, traders can create a robust methodology for identifying NervGen entry and exit points for their positions.

When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.